Showing posts with label Global Prenatal Genetic Testing Research Reports. Show all posts
Showing posts with label Global Prenatal Genetic Testing Research Reports. Show all posts

Prenatal Genetic Testing Market Trend Analysis by 2024 – Natera, Illumina, Agilent Technologies, Bio-Rad Laboratories, Abbott, Cepheid, ElitechGroup, Sequenom, GeneDx, 23andMe, Ambry Genetics, Counsyl, Invitae, Pathway Genomics Corporation


The report “Global Prenatal Genetic Testing Market to 2024”, By Technology {Diagnostics Methods (PCR, aCGH, FISH), Screening Techniques (Non-Invasive Prenatal Tests, Maternal Serum Screening)}; End User (Hospitals, Clinics, Diagnostic Centers); Geography (North America, Europe, Asia-Pacific, South America, Middle East, Africa).

Global Prenatal Genetic Testing Market is accounted for USD 7.2 billion in 2016 growing at a CAGR of 28.85% during the forecast period of 2017 to 2024. The upcoming market reports contain data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.


Market Definition:

Prenatal genetic testing is done to know the birth defects such as Down syndrome, Trisomy 13, Trisomy 18 and others that are associated with genetic disorder of an unborn child before birth or during pregnancy.

On the basis of geography, prenatal genetic testing market is segmented into key regions:

·         North America
·         South America
·         Europe
·         Asia Pacific
·         Middle East & Africa (MEA)

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. North America is the largest market for prenatal genetic testing and is expected to dominate the market throughout the forecast period. Asia Pacific is the fastest growing region in the forecast period.


Report Segmentation:

On the basis of technology:

·         Diagnostic Methods
·         Screening

On the basis of screening techniques:

·         Carrier Screening
·         Sequential Screening
·         Maternal Serum Quad Screening

On the basis of end users:

·         Hospitals
·         Clinics
·         Diagnostic Centres

On the basis of geography:

·         North America
·         South America
·         Europe
·         Asia Pacific
·         Middle East & Africa (MEA)

Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.

 Market Drivers and Restraints:

·         Increasing prevalence of genetic diseases such as Down syndrome, Edward syndrome and Patau syndrome and rising awareness among population.
·         Rising demand for prenatal testing for identifying genetic abnormalities.
·         Increasing R&D activities related to genomics and proteomics
·         Increasing approaches for novel diagnostic techniques and tools
·         Increasing healthcare expenditure
·         High test costs


Competitive Analysis of Global Prenatal Genetic Testing Market:

The prenatal genetic testing market report is highly fragmented and is based on new product launches and clinical results of products. Governmental regulations and standards are playing a major role in sustaining the growth of the market.  Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prenatal genetic testing market for global, Europe, North America, Asia Pacific, and South America.

Major Market Competitors:

·         Bio-Rad Laboratories Inc.
·         Agilent Technologies Inc.
·         Illumina, Inc.
·         Natera Inc.
·         Abbott
·         Cepheid Inc.
·         ELITech Group
·         Autogenomics
·         Sequenom
·         GeneDx
·         23andMe, Inc.
·         Ambry Genetics
·         Ariosa Diagnostics Inc.
·         Counsyl, Inc.
·         Invitae Corporation
·         Pathway Genomics
·         Progenity, Inc.
·         Verinata Health, Inc., among others.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research
Tel: +1–888–387–2818

Powered by Blogger.